Kari Nadeau, MD, PhD

Kari Nadeau, MD, PhD

Allergist, Asthma specialist, Immunologist, Pediatrician

Professor - University Medical Line, Medicine

View Professional Summary »


Dr. Kari Nadeau is the Naddisy Foundation Endowed Professor of Medicine and Pediatrics and Section Chief in Asthma and Allergy in the Pulmonary, Allergy and Critical Care Division at Stanford. She is a world-renowned environmental health expert, especially on air pollution and how it affects the immune system in all ages – and she and her team are now focused on global climate change and wildfire exposures, particularly in underserved areas. She is a member of the NAM, a member of the Federal Wildfire Commission for the U.S., a member of the U.S. EPA Children Protection Committee, and works with the WHO on air pollution and climate change policy and education.

For more than 30 years, she has devoted herself to understanding how environmental and immune/genetic factors affect allergies, immune tolerance, and asthma. She and her team are focused in areas of global climate change and health by studying air pollution and wildfire exposures, particularly in underserved areas. As one of the globe’s foremost experts in adult and pediatric allergy, immunology, and asthma, her research is laying the groundwork for a variety of potential future therapies to prevent and cure allergies and asthma. Dr. Nadeau leads a team of multidisciplinary specialists. She has led research in oncology, transplant, infectious diseases, COVID, and autoimmune trials and is a member of the National Steering Committee at the NIH Immune Tolerance Network. She and her team have been awarded many patents, started 4 biotech companies, and worked in industry to shepherd two drugs through the FDA to approval. She also is an author of the Lancet Countdown in Global Climate Change 2020 and the book: The End of Food Allergy (published 2020).

Dr. Nadeau received her MD and PhD from Harvard Medical School through the NIH MSTP program. She completed a residency in pediatrics at Boston Children’s Hospital and a clinical fellowship in allergy, asthma and immunology at Stanford and at University of California, San Francisco.

Dr. Nadeau has served as a FDA consultant and a reviewer for NIH Study Sections. Also, she served on the environmental health policy committee for the American Thoracic Society, and serves on the Data and Safety Monitoring Board (DSMB) of the National Heart, Lung, and Blood Institute (NHLBI), and is a fellow in the American Academy of Allergy, Asthma, and Immunology (AAAAI). She started the Gordon Research Conference for Food Allergy and Chaired the first inaugural conference (2018). She is Chair of the Board of Scientific Counselors for the NIH Clinical Center (2018-2021). She is a member of the American Society for Clinical Investigation (ASCI), Association of American Physicians (AAP), the medical board of the American Lung Association in California, and in the past, has been a member of the Scientific Advisory Board of the EPA, and is currently working with the US Congress, the WHO, International Wildfire Policy Group, CUGH, and CA Governor’s office on Global Climate Change emergency preparedness plans.

In addition to her above involvements, Dr. Nadeau contributes on multiple editorial boards for high impact journals and to date published over 300 peer-reviewed publications, and is a reviewer for high impact journals in basic science and clinical medicine (Nature, Nature Medicine, Science, Science Translational Medicine, Lancet, NEJM, JAMA, Allergy, JACI).

She is also passionate about breaking down health barriers and creating meaningful change for children and adults in underserved areas and has developed outreach and educational programs with partners in East Palo Alto, Inner City Chicago, Harlem, and San Francisco.

Her work has been recognized with numerous grants and awards. She has collaborated with many organizations and institutions. Through FARE, CoFAR, WHO, the United Nations and other partnerships, she collaborates with colleagues from institutions around the globe.

Professional Summary

Professional Education
  • Board Certification: American Board of Allergy and Immunology, Allergy and Immunology (2007)
  • Fellowship, Stanford University Medical Center - University of California, San Francisco (UCSF), Asthma and Immunology (2006)
  • Residency, Stanford University Medical Center in Stanford, California, Pediatric (2004)
  • Internship and Residency, Children's Hospital of Boston, Pediatric (Special Alternative Pathway) (1997)
  • MD, PhD, Harvard Medical School, Biochemistry and Immunology (1995)
  • B.S., Haverford College, Biology (1988)

Honors & Awards
  • "An Allergy Free World For Every Child" Annual Innovations Lecture, United Nations University (2015)
  • Advisory Board for the EAACI Research and Outreach Committee, European Academy of Allergy and Clinical Immunology (EAACI) (2021-Current)
  • American Society for Clinical Investigation, The American Society of Clinical Investigation (ASCI) (2014)
  • Chair and Founder, GRC Food Allergy, Gordon Research Conference (GRC) (2018)
  • Chair, Board of Scientific Counselors, National Institutes of Health (NIH) Clinical Center (2018-Current)
  • CVI Seed Grant Award, “Single-cell Sequencing to Identify Air Pollution-Induced Cardiac Risks.”, Stanford Cardiovascular Institute (CVI) (2019)
  • Distinguished Member, World Society for Virology (2021-Current)
  • Distinguished Research Award, Food Allergy Research & Education (FARE) (2018)
  • Elected into Association of American Physicians, Association of American Physicians (APA) (2020)
  • EPA Star Grant Award, Environmental Protection Agency (EPA) (2011-2013)
  • Grand Rounds and Pierson Lectureship, University of Washington (2015)
  • Honor Your Doctor - California, Food Allergy Research & Education (FARE) (2020)
  • National Distinguished Scientist Award, American Academy of Allergy, Asthma and Immunology (AAAAI) (2020)
  • Nominee from Stanford Medical School for Warren Alpert Award, Warren Alpert Foundation (2020)
  • Visiting Professorship Lecture, Texas Children’s Hospital (2015)

Administrative Appointments
  • Affiliated Faculty Member, Wu Tsai Neurosciences Institute (2021 - Present)
  • Director, Sean N. Parker Center for Allergy Research at Stanford University (2014 - Present)
  • Faculty Member, Multidisciplinary Program in Immunology (MPI) (2007 - Present)
  • Faculty Member, Stanford Institute of Immunity, Transplantation, and Infectious (ITI) Disease (2007 - Present)
  • Medical Director, Precision Allergy, School of Medicine (2020 - Present)
  • Professor, Affiliate appointment in Otolaryngology (2015 - Present)
  • Professor, Medicine (2016 - Present)
  • Professor, Affiliate appointment in Epidemiology, Department of Epidemiology and Population Health (2020 - Present)
  • Professor of Medicine, Division of Pulmonary, Allergy, Asthma, and Critical Care Medicine (PACCM) (2015 - Present)
  • Professor of Pediatrics, Division of Allergy, Immunology, and Rheumatology (Joint Appointment) (2015 - Present)
  • Section Chief, Allergy and Asthma at the Stanford School of Medicine (2016 - Present)


Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Specializing In

  • Allergen Immunotherapy
  • Allergy Tests
  • Anaphylaxis
  • Angioedema
  • Asthma
  • Contact Dermatitis
  • Eczema
  • Food and Drug Allergies
  • Hives (Urticaria)
  • Infections in Immunocompromised Patients
  • Seasonal Allergies

Practice Locations

SHC- Allergy (Portola Valley) Portola Valley, CA
Portola Valley, CA

3240 Alpine Rd

Portola Valley , CA 94028

(650) 723-6961

More Clinic Information »

Referring Physicians

  • Send referrals online
  • View referral status
  • Access medical records